Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideMRKMerck & Co.
FinDog View：Neutral
REGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | MRK | REGN |
|---|
| Close | 147.15 | 789.45 |
| Market Cap | $358B | $79.7B |
| 1M | +8.86% | −2.57% |
| P/E (TTM) | 112.2 | 18.5 |
| Forward P/E | 19.5 | 14.1 |
| P/E 5-Yr Percentile | 81 | 48 |
| P/S | 5.4 | 5.2 |
| P/B | 8.5 | 2.5 |
| Dividend Yield | 2.87% | 0.47% |
| Latest Quarter Revenue | $16.6B | $4.3B |
| Revenue YoY | +5.1% | +16.7% |
| Gross Margin | 73.5% | — |
| Latest Quarter EPS | -0.54 | 12.23 |
| Avg Post-Earnings Move | ±1.7% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.50% | 4.61% |
| 90-Day Net Insider Buying | −$30.0M | −$3.4M |
MRK · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
